Viridian Therapeutics, Inc. (NASDAQ:VRDN) Q1 2023 Earnings Call Transcript May 13, 2023
Operator: Welcome to the Viridian Therapeutics First Quarter 2023 Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to hand the call over to Ms. Louisa Stone, Manager of Investor Relations for Viridian. Please go ahead.
Louisa Stone: Thank you, and welcome, everyone, to our first quarter 2023 earnings conference call. The press release reporting...
